The result of IHC suggested inhibition of CXCR2 could decrease neutrophil infiltration and attenuate immunosuppression in tumor microenvironment with decreased levels of TGF-β and Arg-1 (Supplementary Fig. 3). The gene discussed is CXCR2; the disease is neoplasm.